"Heparan sulfate proteoglycan biosynthetic process, enzymatic modification"

pathway activity — cross-omics
GO:0015015Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the "Heparan sulfate proteoglycan biosynthetic process, enzymatic modification" pathway is significantly associated with the RNA expression of multiple genes, with the OV cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are MIR4516, MIR6819, and RPL15, each associated with the pathway in up to 3 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile.

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
OVMIR4516 →+1.201+1.470.003.00133
OVMIR6819 →+1.801+1.580<.001<.00133
GBMRPL15 →-0.173-0.586.008.00233
OVNKIRAS2 →+0.817+1.641.006<.00132
OVLRRC37A →+0.562+1.417<.001.00132
OVSNORD15B →-1.072-1.193.009.00732
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

Exploration